In addition to exercise and a balanced diet, supplements like omega-3 can boost cardiovascular health and reduce the risk of ...

Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

With India witnessing a quiet explosion in heart failure cases, many striking working-age adults, STAR Hospitals has launched ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

People with type O blood enjoy a slightly lower risk of heart disease and blood clotting, but they may be more susceptible to hemorrhaging or bleeding disorders. This may be especially true after ...

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...